Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
astrazeneca
3
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
allergan
amgen
biogen
boston top stories
cancer
clinical trials
covid-19
deals
eli lilly
europe blog main
europe top stories
What
bio
roundup
acquisitions
ceo
daniel
gilead
o’day
sciences
announced
august
biggest
biotech
build
busy
buy
collabs
company’s
covid
days
deal
debut
decisions
devices
drug
drugs
dyne’s
fda
gilead’s
help
introduce
ipo
legacy
medicines
microbiome
month
moves
news
nods
openly
opioid
Language
unset
3
×
Current search:
astrazeneca
×
novartis
×
unset
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More